Latest News about DEA
Recent news which mentions DEA
From Benzinga
US Cannabis Stocks Surge By 69%: Water Tower Research Report Breaks Down Top Performers
January 24, 2024
From Benzinga
How to Collect Dividends from the Federal Government
January 24, 2024
From Benzinga
2024 Oscars Of Marijuana Equity: Analyst Nominations Spotlight Key State Performers
January 23, 2024
From Benzinga
DEA Seizes Largest Amount Of Fentanyl In Its History: 386M Lethal Doses, Enough 'To Kill Every America'
January 20, 2024
From Benzinga
Biden's Reelection Hopes Boosted By Youth Support For Weed Reform
January 19, 2024
From Benzinga
Marijuana Reclassification And DEA: Congressional Report Outlines Rescheduling Limits
January 16, 2024
From Benzinga
Cannabis Stocks And ETFs Trading Higher As Government Recommendations Ignite Hope For Industry
January 16, 2024
From Benzinga
EXCLUSIVE: Key Legal And Tax Ramifications Of Federal Cannabis Rescheduling, Insights From Dykema Gossett PLLC
January 16, 2024
Tickers
DEA
From Benzinga
Reschedule Cannabis Or 'Abolish The DEA,' Says Physician: Examining The 50-Year-Old, Trillion-Dollar Agency
January 15, 2024
From Benzinga
DEA's Cannabis Classification: Time To Right A Decades-old Mistake As Feds Confirm Marijuana's Medical Benefits
January 14, 2024
From Benzinga
National Cannabis Roundtable Applauds 'Historic' HHS Recommendation To Reschedule Cannabis
January 13, 2024
From Benzinga
Feds Finally Release Documents Confirming Recommendation To Reschedule Cannabis Based On 'Accepted Medical Use'
January 12, 2024
From Benzinga
12 State Attorneys General To DEA: Reschedule Marijuana To 'Defend Public Safety,' Cannabis Stocks Jump
January 12, 2024
From Benzinga
From Benzinga
Congressman Presses DEA On Marijuana Rescheduling Review: 'Move As Swiftly As Possible'
January 05, 2024
From Benzinga
DEA To Congress: We Hold 'Final Authority' On Cannabis Rescheduling, Overruling Biden's Health Authorities
January 03, 2024
From Benzinga
DEA Raises THC, Psilocybin And DMT Production Quotas For Scientific Research Purposes
January 02, 2024
From Benzinga
Biden Considers Marijuana Rescheduling: Boon Or Bust For The Industry? Former Top FDA Official Weighs In
January 02, 2024
From Benzinga
Tesla Investor Ross Gerber Calls On DEA To Reschedule Cannabis: 'Absurd We're Still Waiting'
December 27, 2023
From Benzinga
Lawsuit Against US Attorney General And Record Cannabis Sales, Two Of Many 2023 Marijuana Milestones
December 27, 2023
From Benzinga
Insiders Buying Chewy And 2 Other Stocks
December 15, 2023
From Benzinga
DEA Threats Rankle Georgia Pharmacies Intending To Legally Sell Medical Marijuana, Advocates Also Irked
December 12, 2023
Tickers
DEA
From Benzinga
DEA Cracks Down On Synthetic Cannabinoids, Classifies These Six As Schedule I Drugs
December 12, 2023
Tickers
DEA
From Benzinga
Federal Agency Finally Releases Info On Cannabis Rescheduling Suggestions To DEA, Most Important Data Redacted
December 08, 2023
From Benzinga
DEA Warns Pharmacies Selling Medical Marijuana In Georgia That THC Oil Is Illegal To Dispense
December 07, 2023
From Benzinga
Congressman Dave Joyce Will Introduce Bill To Reclassify State-Legal Cannabis At Federal Level
December 06, 2023
Tickers
DEA
From Benzinga
How Does Cannabis Reclassification To Schedule III Differ From De-Scheduling & What Is Ideal Reform? Legal Expert Explains
December 06, 2023
From Benzinga
Congressional Report Sheds Light On Hemp's Impact And Future Prospects Amid Farm Bill Renewal Talks
December 04, 2023
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.